SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001178879-22-000014
Filing Date
2022-08-04
Accepted
2022-08-04 16:08:35
Documents
56
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q fold-20220630.htm   iXBRL 10-Q 1306556
2 EX-31.1 fold-06302022xex311.htm EX-31.1 11159
3 EX-31.2 fold-06302022xex312.htm EX-31.2 11232
4 EX-32.1 fold-06302022xex321.htm EX-32.1 8657
  Complete submission text file 0001178879-22-000014.txt   5825509

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fold-20220630.xsd EX-101.SCH 28809
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT fold-20220630_cal.xml EX-101.CAL 72759
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT fold-20220630_def.xml EX-101.DEF 133609
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT fold-20220630_lab.xml EX-101.LAB 475652
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fold-20220630_pre.xml EX-101.PRE 295283
50 EXTRACTED XBRL INSTANCE DOCUMENT fold-20220630_htm.xml XML 1047253
Mailing Address 3675 MARKET STREET PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET PHILADELPHIA PA 19104 (215) 921-7600
AMICUS THERAPEUTICS, INC. (Filer) CIK: 0001178879 (see all company filings)

IRS No.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33497 | Film No.: 221136574
SIC: 2834 Pharmaceutical Preparations